{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:33:03Z","timestamp":1786642383188,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62372280"],"award-info":[{"award-number":["62372280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Fund Project of Shandong University of Chinese Medicine","award":["KYRW2024Q04"],"award-info":[{"award-number":["KYRW2024Q04"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2026MS0989"],"award-info":[{"award-number":["ZR2026MS0989"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01032-9","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:51:31Z","timestamp":1786639891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning"],"prefix":"10.1007","author":[{"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benzheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"3","key":"1032_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2(3):214\u201321. https:\/\/doi.org\/10.1038\/nrd1033.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1032_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines\u2014a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379. https:\/\/doi.org\/10.1038\/nrd.2017.243.","journal-title":"Nat Rev Drug Discov"},{"key":"1032_CR3","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharmaceut. 2021;601:120586. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586.","journal-title":"Int J Pharmaceut"},{"issue":"12","key":"1032_CR4","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, et al. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"issue":"1","key":"1032_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","volume":"5","author":"NA Jackson","year":"2020","unstructured":"Jackson NA, Kester KE, Casimiro D, et al. The promise of mRNA vaccines: a biotech and industrial perspective. Npj Vaccines. 2020;5(1):11. https:\/\/doi.org\/10.1038\/s41541-020-0159-8.","journal-title":"Npj Vaccines"},{"issue":"7","key":"1032_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.013.","journal-title":"Mol Ther"},{"issue":"2","key":"1032_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"},{"key":"1032_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-03626-1","author":"M Cleve","year":"2021","unstructured":"Cleve M What the lightning-fast quest for Covid vaccines means for other diseases. Nature. 2021. https:\/\/doi.org\/10.1038\/d41586-020-03626-1.","journal-title":"Nature"},{"issue":"7942","key":"1032_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-022-05543-x","volume":"613","author":"M Park","year":"2023","unstructured":"Park M, Leahey E, Funk RJ. Papers and patents are becoming less disruptive over time. Nature. 2023;613(7942):138\u201344. https:\/\/doi.org\/10.1038\/s41586-022-05543-x.","journal-title":"Nature"},{"issue":"18","key":"1032_CR10","doi-asserted-by":"publisher","first-page":"2300105","DOI":"10.1016\/j.xphs.2015.11.015","volume":"12","author":"Z Wang","year":"2023","unstructured":"Wang Z, Ye Q, Yu S, et al. Poly ethylene glycol (PEG)-based hydrogels for drug delivery in cancer therapy: a comprehensive review. Adv Healthc Mater. 2023;12(18):2300105. https:\/\/doi.org\/10.1016\/j.xphs.2015.11.015.","journal-title":"Adv Healthc Mater"},{"key":"1032_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","volume":"351","author":"M Ibrahim","year":"2022","unstructured":"Ibrahim M, Ramadan E, Elsadek NE, et al. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. J Control Release. 2022;351:215\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.031.","journal-title":"J Control Release"},{"issue":"2","key":"1032_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/09205063.2020.1825304","volume":"32","author":"D Yadav","year":"2021","unstructured":"Yadav D, Dewangan HK. PEGYLATION: an important approach for novel drug delivery system. J Biomater Sci Polym Ed. 2021;32(2):266\u201380. https:\/\/doi.org\/10.1080\/09205063.2020.1825304.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"37","key":"1032_CR13","doi-asserted-by":"publisher","first-page":"21693","DOI":"10.1039\/D5NR01680K","volume":"17","author":"K Zhang","year":"2025","unstructured":"Zhang K, Li M, Sui D, et al. Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation. Nanoscale. 2025;17(37):21693\u2013705. https:\/\/doi.org\/10.1039\/D5NR01680K.","journal-title":"Nanoscale"},{"issue":"6","key":"1032_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/10837450.2023.2214201","volume":"28","author":"J Zhou","year":"2023","unstructured":"Zhou J, Tong Y, Zhu W, et al. Combination immunotherapy of PEG-modified preladenant thermosensitive liposomes and PD-1 inhibitor effectively enhances the anti-tumor immune response and therapeutic effects. Pharm Dev Technol. 2023;28(6):501\u20138. https:\/\/doi.org\/10.1080\/10837450.2023.2214201.","journal-title":"Pharm Dev Technol"},{"key":"1032_CR15","doi-asserted-by":"publisher","first-page":"123673","DOI":"10.1016\/j.ijpharm.2023.123673","volume":"649","author":"C Liu","year":"2024","unstructured":"Liu C, Zhang X, Yang H, et al. PEG-modified nano liposomes co-deliver Apigenin and RAGE-siRNA to protect myocardial ischemia injury. Int J Pharmaceut. 2024;649:123673. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123673.","journal-title":"Int J Pharmaceut"},{"key":"1032_CR16","doi-asserted-by":"publisher","first-page":"104122","DOI":"10.1016\/j.jddst.2022.104122","volume":"80","author":"T Shehata","year":"2023","unstructured":"Shehata T, Kono Y, Higaki K, et al. In vivo distribution characteristics and anti-tumor effects of doxorubicin encapsulated in PEG-modified niosomes in solid tumor-bearing mice. J Drug Deliv Sci Tec. 2023;80:104122. https:\/\/doi.org\/10.1016\/j.jddst.2022.104122.","journal-title":"J Drug Deliv Sci Tec"},{"issue":"6","key":"1032_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/pharmaceutics17060798","volume":"17","author":"J Song","year":"2025","unstructured":"Song J, Su D, Wu H, et al. Implications of anaphylaxis following mRNA-LNP vaccines: it is urgent to eliminate PEG and find alternatives. Pharmaceutics. 2025;17(6):798. https:\/\/doi.org\/10.3390\/pharmaceutics17060798.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1032_CR18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1086\/723636","volume":"131","author":"D Hegde","year":"2023","unstructured":"Hegde D, Herkenhoff K, Zhu C. Patent publication and innovation. J Polit Econ. 2023;131(7):1845\u2013903. https:\/\/doi.org\/10.1086\/723636.","journal-title":"J Polit Econ"},{"key":"1032_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.wpi.2013.12.006","volume":"37","author":"A Abbas","year":"2014","unstructured":"Abbas A, Zhang L, Khan SU. A literature review on the state-of-the-art in patent analysis. World Pat Inf. 2014;37:3\u201313. https:\/\/doi.org\/10.1016\/j.wpi.2013.12.006.","journal-title":"World Pat Inf"},{"issue":"12","key":"1032_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41587-020-00749-8","volume":"38","author":"L Lyu","year":"2020","unstructured":"Lyu L, Feng Y, Chen X, et al. The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape. Nat Biotechnol. 2020;38(12):1387\u201394. https:\/\/doi.org\/10.1038\/s41587-020-00749-8.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1032_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nbt.4291","volume":"36","author":"JA Smith","year":"2018","unstructured":"Smith JA, Arshad Z, Trippe A, et al. The reporting items for patent landscapes statement. Nat Biotechnol. 2018;36(11):1043\u20137. https:\/\/doi.org\/10.1038\/nbt.4291.","journal-title":"Nat Biotechnol"},{"key":"1032_CR22","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1109\/TEM.2022.3207376","volume":"71","author":"Z Erdogan","year":"2022","unstructured":"Erdogan Z, Altuntas S, Dereli T. Predicting patent quality based on machine learning approach. IEEE T Eng Manage. 2022;71:3144\u201357. https:\/\/doi.org\/10.1109\/TEM.2022.3207376.","journal-title":"IEEE T Eng Manage"},{"key":"1032_CR23","doi-asserted-by":"publisher","first-page":"120146","DOI":"10.1016\/j.techfore.2020.120146","volume":"158","author":"P Chung","year":"2020","unstructured":"Chung P, Sohn SY. Early detection of valuable patents using a deep learning model: Case of semiconductor industry. Technol Forecast Soc. 2020;158:120146. https:\/\/doi.org\/10.1016\/j.techfore.2020.120146.","journal-title":"Technol Forecast Soc"},{"key":"1032_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041941","author":"JM Cohen","year":"2012","unstructured":"Cohen JM, Fagin AP, Hariton E, et al Therapeutic intervention for chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): a systematic review and meta-analysis. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0041941.","journal-title":"PLoS ONE"},{"issue":"10","key":"1032_CR25","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/aac.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman O, Avni T, Leibovici L, et al. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Ch. 2013;57(10):5104\u201311. https:\/\/doi.org\/10.1128\/aac.01230-13.","journal-title":"Antimicrob Agents Ch"},{"key":"1032_CR26","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.cpr.2022.102144","volume":"93","author":"L O\u2019halloran","year":"2022","unstructured":"O\u2019halloran L, Coey P, Wilson C. Suicidality in autistic youth: A systematic review and meta-analysis. Clin Psychol Rev. 2022;93:102144. https:\/\/doi.org\/10.1016\/j.cpr.2022.102144.","journal-title":"Clin Psychol Rev"},{"key":"1032_CR27","doi-asserted-by":"publisher","first-page":"188833","DOI":"10.1109\/ACCESS.2020.3030960","volume":"8","author":"M Kim","year":"2020","unstructured":"Kim M, Geum Y. Predicting patent transactions using patent-based machine learning techniques. IEEE Access. 2020;8:188833\u201343. https:\/\/doi.org\/10.1109\/ACCESS.2020.3030960.","journal-title":"IEEE Access"},{"key":"1032_CR28","unstructured":"United States Patent and Trademark Office. USPTO report examines the impact of Chinese government subsidies and other non-market factors on the recent rise in patent and trademark filings in China. https:\/\/www.uspto.gov\/about-us\/news-updates\/breaking-news-uspto-report-examines-impact-chinese-government-subsidies-and"},{"issue":"12","key":"1032_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/d41573-020-00184-z","volume":"19","author":"L Robke","year":"2020","unstructured":"Robke L, Pont LB, Bongard J, et al. Impact of COVID-19 on pharmaceutical external innovation sourcing. Nat Rev Drug Discov. 2020;19(12):829\u201330. https:\/\/doi.org\/10.1038\/d41573-020-00184-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"27","key":"1032_CR30","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"New Engl J Med"},{"issue":"8","key":"1032_CR31","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1016\/j.apsb.2023.01.011","volume":"13","author":"S Song","year":"2023","unstructured":"Song S, Sun D, Wang H, et al. Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug. Acta Pharm Sin B. 2023;13(8):3444\u201353. https:\/\/doi.org\/10.1016\/j.apsb.2023.01.011.","journal-title":"Acta Pharm Sin B"},{"key":"1032_CR32","doi-asserted-by":"publisher","first-page":"100160","DOI":"10.1016\/j.mtbio.2021.100160","volume":"12","author":"K Utatsu","year":"2021","unstructured":"Utatsu K, Kogo T, Taharabaru T, et al. Supramolecular polymer-based transformable material for reversible PEGylation of protein drugs. Mater Today Bio. 2021;12:100160. https:\/\/doi.org\/10.1016\/j.mtbio.2021.100160.","journal-title":"Mater Today Bio"},{"issue":"45","key":"1032_CR33","doi-asserted-by":"publisher","first-page":"22006","DOI":"10.1039\/C9NR05478B","volume":"11","author":"VS Madamsetty","year":"2019","unstructured":"Madamsetty VS, Pal K, Keshavan S, et al. Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer. Nanoscale. 2019;11(45):22006\u201318. https:\/\/doi.org\/10.1039\/C9NR05478B.","journal-title":"Nanoscale"},{"issue":"4","key":"1032_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10961-010-9160-0","volume":"36","author":"F Kohler","year":"2011","unstructured":"Kohler F. Patent cross-licensing, the influence of IP interdependency and the moderating effect of firm size. J Technol Transf. 2011;36(4):448\u201367. https:\/\/doi.org\/10.1007\/s10961-010-9160-0.","journal-title":"J Technol Transf"},{"issue":"1","key":"1032_CR35","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.jik.2022.100287","volume":"8","author":"W Tu","year":"2023","unstructured":"Tu W, Zhang L, Sun D, et al. Evaluating high-tech industries\u2019 technological innovation capability and spatial pattern evolution characteristics: Evidence from China. J Innov Knowl. 2023;8(1):100287. https:\/\/doi.org\/10.1016\/j.jik.2022.100287.","journal-title":"J Innov Knowl"},{"issue":"10","key":"1032_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/d41573-023-00102-z","volume":"22","author":"A Schuhmacher","year":"2023","unstructured":"Schuhmacher A, Hinder M, Dodel A, et al. Investigating the origins of recent pharmaceutical innovation. Nat Rev Drug Discov. 2023;22(10):781\u20132. https:\/\/doi.org\/10.1038\/d41573-023-00102-z.","journal-title":"Nat Rev Drug Discov"},{"key":"1032_CR37","first-page":"289","volume":"68","author":"C Mulligan","year":"2012","unstructured":"Mulligan C, Lee TB. Scaling the patent system. NYU Ann Surv Am L. 2012;68:289.","journal-title":"NYU Ann Surv Am L"},{"key":"1032_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.wpi.2018.05.001","volume":"53","author":"L Aristodemou","year":"2018","unstructured":"Aristodemou L, Tietze F. Citations as a measure of technological impact: A review of forward citation-based measures. World Pat Inf. 2018;53:39\u201344. https:\/\/doi.org\/10.1016\/j.wpi.2018.05.001.","journal-title":"World Pat Inf"},{"key":"1032_CR39","doi-asserted-by":"publisher","unstructured":"Harhoff D, Wagner S. Modeling the duration of patent examination at the European Patent Office. 2006. https:\/\/doi.org\/10.5282\/ubm\/epub.1256","DOI":"10.5282\/ubm\/epub.1256"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01032-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:51:33Z","timestamp":1786639893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":39,"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01032-9","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}